Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-6,531
Closed -$308K – 888
2025
Q3
$308K Buy
6,531
+305
+5% +$14.7K ﹤0.01% 697
2025
Q2
$301K Buy
6,226
+238
+4% +$12.2K ﹤0.01% 684
2025
Q1
$332K Sell
5,988
-636
-10% -$34.4K ﹤0.01% 634
2024
Q4
$319K Buy
6,624
+18
+0.3% +$915 ﹤0.01% 562
2024
Q3
$381K Hold
6,606
– – 0.01% 521
2024
Q2
$321K Sell
6,606
-2,093
-24% -$101K ﹤0.01% 531
2024
Q1
$423K Sell
8,699
-467
-5% -$22.8K 0.01% 483
2023
Q4
$456K Sell
9,166
-37
-0.4% -$1.81K 0.01% 462
2023
Q3
$494K Buy
9,203
+780
+9% +$41.6K 0.01% 438
2023
Q2
$454K Buy
8,423
+10
+0.1% +$538 0.01% 461
2023
Q1
$458K Buy
8,413
+3,965
+89% +$193K 0.01% 457
2022
Q4
$215K Buy
+4,448
New +$195K ﹤0.01% 591
2022
Q3
– Sell
-5,202
Closed -$260K – 635
2022
Q2
$260K Buy
5,202
+16
+0.3% +$849 0.01% 563
2022
Q1
$266K Hold
5,186
– – ﹤0.01% 589
2021
Q4
$260K Hold
5,186
– – ﹤0.01% 593
2021
Q3
$250K Hold
5,186
– – ﹤0.01% 592
2021
Q2
$273K Buy
5,186
+488
+10% +$25.5K 0.01% 570
2021
Q1
$232K Sell
4,698
-1,200
-20% -$57.6K ﹤0.01% 571
2020
Q4
$286K Sell
5,898
-645
-10% -$31.8K 0.01% 513
2020
Q3
$328K Buy
6,543
+828
+14% +$42.6K 0.01% 457
2020
Q2
$292K Buy
+5,715
New +$278K 0.01% 463

Other funds holding SNY

Fiduciary Trust's SNY Position: Q4 2025 in Review

Fiduciary Trust sold out of Sanofi (SNY) in Q4 2025, closing a stake of 6,531 shares — an estimated $308K sold.

Fiduciary Trust first reported a position in SNY in Q2 2020 and held it in 21 quarters. The position peaked at $494K in Q3 2023. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Fiduciary Trust reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Fiduciary Trust sold 6,531 Sanofi shares in Q4 2025, an estimated $308K.
  • Fiduciary Trust first reported a position in Sanofi in Q2 2020 and held it in 21 quarters.
  • Fiduciary Trust's Sanofi position peaked at $494K in Q3 2023.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Fiduciary Trust's 13F filing for Q4 2025, filed 13 Feb 2026.